Both in Pharmaceuticals
LB Pharmaceuticals vs Damora Therapeutics
Over the past year LBRX returned −11.0% and DMRA returned −23.5%; their daily moves had a correlation of 0.63.
LBRX −11.0% DMRA −23.5%Growth of $1, one year, split-adjusted
| Metric | LBRX | DMRA |
|---|---|---|
| Price | $39.70 | $21.49 |
| Market cap | $1.28B | $1.33B |
| Today | −1.12% | −2.36% |
| 1 month | +6.5% | +6.2% |
| 6 months | +26.3% | — |
| Year to date | +78.3% | — |
| 1 year | +153.7% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $327.8M | $540.5M |
| Dividend yield | — | — |
| Volatility (60d) | 51.6% | — |
| Short % of float | 23.0% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).